23andMe has found itself a buyer after biotech Regeneron won an auction to buy the bankrupt genetics company for $256m. As part of a court-supervised sale, the auction will see Regeneron acquire ...

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...

The State Congress on Tuesday installed flex boards and put up posters with photographs of former Prime Minister Indira Gandhi, highlighting her leadership during the 1971 India-Pakistan war ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s ...

Regeneron has since re-filed the BCMAxCD3 drug in the U.S., and it's now awaiting a July 10 decision target date. With linvoseltamab's delayed arrival in the U.S., the multiple myeloma bispecific ...

STORY: Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy. It also promised to prioritize the ethical use of customers ...

Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients ...

NEW YORK (WRGB) — Regeneron Pharmaceuticals, Inc, the New York based company, announced it has emerged as the successful bidder in the bankruptcy auction for nearly all assets of 23andMe Holding ...

Former Deputy Chief Minister C.N. Ashwath Narayan, who addressed a press conference after releasing the posters, said the Congress government had ruined the lives of the people who had brought the ...

Congress workers in Hyderabad celebrated the Centre's decision to conduct a caste census by pouring milk on posters of Rahul Gandhi and Telangana CM Revanth Reddy. Image credit: ANI NEW DELHI ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...